Skip to content
Screener

Abbott ABT Q3 2025 earnings

Reported October 15, 2025 · Before market open

Revenue$11.4BMiss by $20.7M
EPS$1.30In line
Revenue estimate$11.4B
EPS estimate$1.30

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$13.0B
EPS estimate$1.42

Financials

Q3 2025

Income statement

See full
Revenue$11.4B+6.9%
Gross profit$6.3B+6.0%
Operating income$2.1B+10.7%
Net income$1.6B-0.1%
EPS (diluted)$0.940.0%

Balance sheet

See full
Cash & equivalents$7.5B-0.6%
Total debt$12.9B-13.6%
Total equity$51.0B+28.0%
Total assets$84.2B+13.2%

Cash flow

See full
Operating cash flow$2.8B+3.0%
CapEx$496.0M-10.8%
Free cash flow$2.3B+6.6%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$233.12B+17.5%
Enterprise value$238.55B+15.9%
P/E16.7×-17.7×
P/S5.3×+0.5×

Profitability

See full
Gross margin55.9%+0.3pp
Operating margin17.6%+1.4pp
Net margin31.9%+17.9pp
FCF margin15.8%0.0pp

Returns & leverage

See full
Return on equity30.8%+15.9pp
Debt / equity0.3×-0.1×
Current ratio1.7×+0.1×

Segments

By segment

See full
Medical Devices$5.4B+14.8%
Diagnostic Products$2.3B-6.6%
Nutritional Products$2.2B+4.2%
Established Pharmaceuticals$1.5B+7.5%

FAQ

When did Abbott report Q3 2025 earnings?
Abbott (ABT) reported Q3 2025 earnings on October 15, 2025 before market open.
What were Abbott's Q3 2025 revenue and EPS?
Abbott reported revenue of $11.4B and eps of $1.30 for Q3 2025.
Did Abbott beat estimates in Q3 2025?
Revenue missed the consensus estimate of $11.4B by $20.7M. EPS beat the consensus estimate of $1.30 by $0.00.
How did Abbott's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.9% from $10.6B a year earlier and eps grew 7.4% from $1.21.
Where can I find Abbott's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-045049) and the 10-Q periodic report (0001628280-25-047131) directly on SEC EDGAR. The filing index links above go to sec.gov.